Hybrid Cardiac Rehabilitation Program for People With Heart Failure
Tests a combined rehabilitation program of exercise, diet and support in adults with heart failure.
Plain-language title generated from the registry record
Registry title: Comprehensive Hybrid Cardiac Rehabilitation Trial on Heart Failure
Key facts
- Where
- Santiago and Temuco, ChileSee the 4 sites
Where in Chile
- Complejo Hospitalario San JoséSantiago, ChileTaking people
- Hospital Clínico Universidad de ChileSantiago, ChileTaking people
- Hospital San Borja ArriaránSantiago, ChileTaking people
- Universidad de La FronteraTemuco, ChileTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universidad de La Frontera
- Trial code
- NCT06313684
- Record updated
- 3 December 2024
- Original description
CO-CREATION-HF aims to evaluate the effectiveness of a comprehensive and hybrid cardiac rehabilitation model compared to supervised exercise alone.Read full original descriptionShow less
Comprehensive Hybrid Cardiac Rehabilitation Trial to Assess Impact on Heart Failure Patients
CO-CREATION-HF aims to evaluate the effectiveness of a comprehensive and hybrid cardiac rehabilitation model compared to supervised exercise alone.
Inclusion: Adult patients with HF of New York Heart Association functional class II or III; Meets HF diagnostic criteria of Guidelines; On optimal tolerated medical therapy; Deemed by the treating physician as stable for at least 1 month; Able to attend the health center three times a week for the first month, and twice a week for the 2nd and 3rd months; Owns a mobile phone; Patient consents to participate in the study by signing an informed consent form.
Exclusion: Cardiac device or cardiac surgery in the previous month or planned in the next 3 months; Chronic kidney disease with glomerular filtration rate < 20 mL/min; Decompensated thyroid disease; End-stage liver failure or Child-Pugh C; Patients with dyspnea predominantly of non-cardiac cause (e.g. COPD); Atrial fibrillation with a heart rate greater than 90 beats per minute at rest; Musculoskeletal or neurological disease that precludes the patient from performing exercise; Active neoplasm with life expectancy <2 years; Inclusion in another interventional study; Explicit contraindications to performing exercise; Comorbidities that preclude the patient from engaging in a CR program.